---
title: 'Outcome of rare primary malignant bone sarcoma (RPMBS) treated with multimodal
  therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S)'
date: '2023-08-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37530385/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230802180849&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The survival of patients who had RPMBS in the current series
  was similar to that of age-matched patients who had high-grade osteosarcoma treated
  according to the same protocol. An osteosarcoma-like chemotherapy may be proposed
  in patients who have ...'
disable_comments: true
---
CONCLUSIONS: The survival of patients who had RPMBS in the current series was similar to that of age-matched patients who had high-grade osteosarcoma treated according to the same protocol. An osteosarcoma-like chemotherapy may be proposed in patients who have ...